Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.04 – $0.62
2% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $21.5K |
| Cost of revenue | $12.1K | $43.8K | $50.3K | $93.4K | $113.2K | $37.5K |
| Gross profit | −$12.1K | −$43.8K | −$50.3K | −$93.4K | −$113.2K | −$16.0K |
| Gross margin | — | — | — | — | — | -74.4% |
| R&D | $508.3K | $2.7M | $4.1M | $2.5M | $1.2M | $820.9K |
| Operating income | −$645.6K | −$4.7M | −$6.0M | −$5.1M | −$3.9M | −$2.2M |
| EBITDA | −$633.5K | −$4.7M | −$5.9M | −$5.2M | −$3.8M | −$2.2M |
| Net income | −$834.2K | −$4.7M | −$6.0M | −$5.2M | −$4.1M | −$2.3M |
| Net margin | — | — | — | — | — | -10893.2% |
| EPS (diluted) | -0.02 | -0.10 | -0.10 | -0.07 | -0.06 | -0.03 |
Annual figures · source: Financial Modeling Prep
GEMINA LABORATORIES LTD
No one on the platform currently holds GLABF.
No tracked institution reports a position in GLABF as of their last filing.
No one on the platform has traded GLABF yet.
| $1M |
| — |
| PRVCFPreveCeutical Medical Inc. | $0.01 | +6.93% | $6M | — |
| QPTFFQuest PharmaTech Inc. | $0.03 | +0.00% | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.